Ezio Bonvini
Vermögen: 748 064 $ am 30.09.2026
Vermögen: 748 064 $ am 30.09.2026
Dr. Ezio Bonvini, MD, is a Chief Scientific Officer & Senior VP-Research at MacroGenics, Inc. Dr. Bonvini was previously employed as a Chief-Laboratory Of Immunobiology by Center for Biologics Evaluation & Research, a Principal by National Cancer Institute, a Principal by National Institutes of Health, and a Principal by US Food & Drug Administration.
He received his undergraduate degree from Scientific Lyceum Cassini and a doctorate degree from the University of Genoa School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MACROGENICS, INC. 0,3 % | 06.10.2026 | 193.799 ( 0,3 % ) | 748 064 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MACROGENICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2003 |
| Unternehmen | Position | Ende |
|---|---|---|
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Corporate Officer/Principal | 01.01.2003 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
University of Genoa School of Medicine
University of Genoa School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scientific Lyceum Cassini
Scientific Lyceum Cassini Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen